Scoop has an Ethical Paywall
Scoop InfoPages
This InfoPage in unregistered, if this is your news page register PHARMAC for InfoPages here.
PHARMAC - Latest News [Page 1]
Thousands Benefit From Pharmac Decision To Fund Oestradiol Gel
Thursday, 26 September 2024, 3:07 pm | PHARMAC
Oestradiol is mainly used as a hormone treatment for people whose bodies don’t produce enough oestrogen, usually as a patch placed on the person’s skin. However, global supply issues means that the patches are not always available in New Zealand. More >>
Making More New Cancer Treatments Available For New Zealanders
Wednesday, 18 September 2024, 11:34 am | PHARMAC
“If Pharmac approves funding for these medicines, they have the potential to benefit hundreds of people with cancer,” says Dr David Hughes, Pharmac’s Chief Medical Officer. More >>
5,700 People To Benefit From Widened Access To Funded Medicines
Tuesday, 17 September 2024, 6:48 pm | PHARMAC
These treatments will help people manage the symptoms they experience on a daily basis – supporting their health and wellbeing. The decision includes treatments for schizophrenia, low iron levels, constipation, and severe psoriasis of the genitals ... More >>
First Cancer Medicine Decision Following Pharmac Funding Boost
Monday, 16 September 2024, 2:02 am | PHARMAC
Pharmac will expand access to Pembrolizumab and Nivolumab for various cancers, benefiting thousands and improving patient survival from October and November 2024. More >>
Pharmac To Fund Continuous Glucose Monitors For Thousands Of People With Type 1 Diabetes
Friday, 13 September 2024, 10:36 pm | PHARMAC
About 12,000 people with type 1 diabetes are expected to receive CGMs in the first year of funding, rising to more than 18,000 after five years. There are about 4,800 people currently using insulin pumps and Pharmac expects this number to increase ... More >>
Proposal To Fund Medicines For Lung Cancer, Breast Cancer And Respiratory Conditions
Friday, 13 September 2024, 12:15 pm | PHARMAC
If approved, Pharmac estimates that in the first year of funding about 300 people would benefit from the funding of osimertinib and trastuzumab deruxtecan. More >>
New Medicine And An Easier Renewal Process Proposed For People With ADHD
Thursday, 12 September 2024, 12:23 pm | PHARMAC
Pharmac – Te Pātaka Whaioranga is asking for feedback on two changes for people with attention deficit hyperactivity disorder (ADHD) - a new medicine, and changes to the renewal criteria. Pharmac is proposing: to fund lisdexamfetamine – known ... More >>
Pharmac Proposes To Widen Access To Medicine Used In The Treatment Of Heart Failure
Tuesday, 20 August 2024, 11:41 am | PHARMAC
Pharmac is consulting on plans to widen access to empagliflozin, a medicine used in the treatment of chronic heart failure that would benefit more than 18,000 people in the first year of funding. More >>
Pharmac Indicates Interest In Funding Cancer Treatment Bevacizumab
Friday, 9 August 2024, 10:37 am | PHARMAC
“Today, we have issued a Future Procurement Opportunity (FPO) for the cancer treatment bevacizumab,” says Pharmac’s Chief Medical Officer, Dr David Hughes. More >>
Significant Step Forward Proposed For Bowel Cancer
Monday, 5 August 2024, 11:07 am | PHARMAC
Public consultation has opened on Pharmac’s proposal to fund cetuximab (branded as Erbitux) for a type of bowel cancer where the cancer is located on the left side of the bowel and has spread to other parts of the body. More >>
Pharmac Closes Inactive Medicine Applications For Greater Clarity
Thursday, 1 August 2024, 2:27 pm | PHARMAC
Chief Executive Sarah Fitt says closing these applications is an important part of ensuring Pharmac’s work is transparent and easy to understand. More >>
Pharmac Opens Consultation On Oestradiol Gel
Thursday, 25 July 2024, 11:35 am | PHARMAC
Pharmac’s Director of Equity and Engagement Dr Nicola Ngawati says that if approved, more than 18,000 people would benefit in the first year of funding. More >>
More Funded Nutritional Supplements On The Way
Friday, 19 July 2024, 9:25 am | PHARMAC
Pharmac – Te Pātaka Whaioranga is funding more nutritional supplements for people living with inherited metabolic diseases. More >>
Pharmac Proposes To Widen Access To Urinary Tract Infection Treatment And Fund A New Epilepsy Treatment
Thursday, 18 July 2024, 1:06 pm | PHARMAC
Pharmac would like to hear from people who have experienced urinary tract infections or epilepsy, their whānau, clinicians and others in the health sector about the proposed eligibility criteria for both of these medicines. More >>
Pharmac Proposal To Increase Access To Five Medicines For Cancer And Other Health Conditions
Friday, 12 July 2024, 11:16 am | PHARMAC
Pharmac – Te Pātaka Whaioranga is looking to increase access to five medicines for a number of cancers, including kidney and lung cancers, and other health conditions. More >>
Over 6,000 People Will Benefit From Pharmac Funding Proposal If Approved
Wednesday, 10 July 2024, 11:40 am | PHARMAC
Pharmac – Te Pātaka Whaioranga plans to widen access to seven medicines benefitting over 6,000 people within the first 12 months of funding. More >>
Pharmac Opens First Consultation For Cancer Medicines After Funding Boost
Friday, 5 July 2024, 11:20 am | PHARMAC
Pharmac – Te Pātaka Whaioranga is looking to widen access to four medicines as part of the first public consultation following the budget boost. More >>
Multiple Myeloma Treatments Available To More People
Tuesday, 2 July 2024, 1:33 pm | PHARMAC
Pharmac – Te Pātaka Whaioranga is making more treatment options available for people with multiple myeloma and other blood disorders. “From 1 August, we’re widening access to lenalidomide and we’re also funding pomalidomide for the first ... More >>
Funding Boost Means More Medicines For More New Zealanders
Monday, 24 June 2024, 4:35 pm | PHARMAC
Pharmac welcomes the Government’s funding boost which will see about 175,000 more people receiving the medicines they need in the first year. More >>
More Funded Nutritional Supplements On The Cards For People With Inherited Metabolic Diseases
Thursday, 20 June 2024, 2:13 pm | PHARMAC
Pharmac – Te Pātaka Whaioranga is proposing to fund more nutritional supplements for people with inherited metabolic diseases and make them available to people closer to home. More >>
